Today we’re diving into how medications like semaglutide, tirzepatide, and retatrutide work in the body—and how they compare to the hormones your body naturally produces. Once you understand the biology behind them, their effects start to make a lot more sense. What is a peptide? Let’s start with the basics. A peptide is a molecule […]
Latest Articles
Glucose 101 — How Blood Sugar Shapes Your Health
Today we’re talking about glucose — what it is, why your body absolutely needs it, and how the way glucose enters your bloodstream affects your energy, weight, hormones, inflammation, and long-term health. Glucose often gets a bad reputation, but the truth is much more nuanced. Glucose itself isn’t the problem. In fact, without it, you […]
Oral Semaglutide
Today, we’re diving into an exciting development in obesity treatment—oral semaglutide. Last week, the FDA approved Novo Nordisk’s Wegovy pill as the first and only oral GLP-1 for weight loss in adults. This approval is based on results from the OASIS-4 phase 3 clinical trial showing that a once-daily oral version of semaglutide can deliver […]
DSIP Peptide Therapy for Sleep
Today we’re talking about sleep — something that affects every system in the body, yet is often overlooked until it becomes a problem. Not just how many hours you’re in bed, but how deeply you sleep, how well your body restores overnight, and whether you actually wake up feeling rested. We’re also going to talk […]
NAD+, GHK-Cu, and the Push Patch
Today, we’re diving into the combined power of high-dose NAD+ and GHK-Cu. I’m genuinely excited about the technology behind a product called the Push Patch. It uses iontophoresis— which is a completely non-invasive technology that uses gentle electrical currents to push these ingredients deep into the skin and directly into circulation. But really, this episode […]
GLP-1 Therapies Strategies: Weekly, Micro-Dose, and Maintenance
Today, we’re diving into GLP‑1 therapies, including dual GIP/GLP‑1 agonists and the emerging triple agonists, and talking about how these peptides are typically dosed, what people are experimenting with, and what the research — or real-world experience — tells us so far. Most GLP‑1 receptor agonists, as well as dual and triple agonists, are designed […]